INSM - Insmed Incorporated

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
61,709
9,835
0
0
0
Cost of Revenue
11,492
2,423
-
-
0
Gross Profit
50,217
7,412
-
-
0
Operating Expenses
Research Development
144,204
145,283
109,749
122,721
74,277
Selling General and Administrative
205,648
168,218
79,171
50,679
43,216
Total Operating Expenses
353,597
314,750
188,920
173,400
117,493
Operating Income or Loss
-303,380
-307,338
-188,920
-173,400
-117,493
Interest Expense
25,170
25,472
5,925
3,498
2,889
Total Other Income/Expenses Net
9,098
8,734
1,924
723
228
Income Before Tax
-319,565
-324,076
-192,921
-176,175
-120,154
Income Tax Expense
418
201
-272
98
-1,971
Income from Continuing Operations
-319,983
-324,277
-192,649
-176,273
-118,183
Net Income
-319,983
-324,277
-192,649
-176,273
-118,183
Net Income available to common shareholders
-319,983
-324,277
-192,649
-176,273
-118,183
Reported EPS
Basic
-
-4.22
-2.89
-2.85
-2.02
Diluted
-
-4.22
-2.89
-2.85
-2.02
Weighted average shares outstanding
Basic
-
76,889
66,576
61,892
58,633
Diluted
-
76,889
66,576
61,892
58,633
EBITDA
-
-297,355
-186,996
-172,677
-117,265